201 related articles for article (PubMed ID: 37210571)
1. Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.
Nagy G; Dobrota R; Becker MO; Minier T; Varjú C; Kumánovics G; Distler O; Czirják L
Arthritis Res Ther; 2023 May; 25(1):84. PubMed ID: 37210571
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire.
Becker MO; Dobrota R; Garaiman A; Debelak R; Fligelstone K; Tyrrell Kennedy A; Roennow A; Allanore Y; Carreira PE; Czirják L; Denton CP; Hesselstrand R; Sandqvist G; Kowal-Bielecka O; Bruni C; Matucci-Cerinic M; Mihai C; Gheorghiu AM; Mueller-Ladner U; Sexton J; Kvien TK; Heiberg T; Distler O
Ann Rheum Dis; 2022 Apr; 81(4):507-515. PubMed ID: 34824049
[TBL] [Abstract][Full Text] [Related]
3. [Evaluations and analyses of quality of life in 90 patients with systemic sclerosis by health assessment questionnaire-disability index].
Mao X; Sun Q
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(44):3471-4. PubMed ID: 25622735
[TBL] [Abstract][Full Text] [Related]
4. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes.
Ingegnoli F; Carmona L; Castrejon I
Semin Arthritis Rheum; 2017 Apr; 46(5):609-614. PubMed ID: 27839740
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of a home-based program for hands in patients with systemic sclerosis.
Landim SF; Bertolo MB; Marcatto de Abreu MF; Del Rio AP; Mazon CC; Marques-Neto JF; Poole JL; de Paiva Magalhães E
J Hand Ther; 2019; 32(3):313-321. PubMed ID: 29198478
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.
Hesselstrand R; Nilsson JÅ; Sandqvist G
Scand J Rheumatol; 2013; 42(4):317-24. PubMed ID: 23442162
[TBL] [Abstract][Full Text] [Related]
7. Investigating performance-based hand functions in patients with systemic sclerosis.
Akatay EA; Bayraktar D; Otman E; Ustun O; Kurut Aysin I; Sarac DC; Atalay B; Ramazanoglu I; Tekin I; Kurum T; Gucenmez S; Ozmen M; Akar S
Z Rheumatol; 2024 Feb; 83(Suppl 1):183-190. PubMed ID: 36074183
[TBL] [Abstract][Full Text] [Related]
8. Reliability, Validity, and Sensitivity to Change of the Cochin Hand Functional Disability Scale and Testing the New 6-Item Cochin Hand Functional Disability Scale in Systemic Sclerosis.
Gheorghiu AM; Gyorfi H; Capotă R; Matei A; Oneaţă R; Bojincă M; Stoica V; Mihai C
J Clin Rheumatol; 2021 Apr; 27(3):102-106. PubMed ID: 31703022
[TBL] [Abstract][Full Text] [Related]
9. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.
Peytrignet S; Denton CP; Lunt M; Hesselstrand R; Mouthon L; Silman A; Pan X; Brown E; Czirják L; Distler JHW; Distler O; Fligelstone K; Gregory WJ; Ochiel R; Vonk M; Ancuta C; Ong VH; Farge D; Hudson M; Matucci-Cerinic M; Balbir-Gurman A; Midtvedt Ø; Jordan AC; Stevens W; Moinzadeh P; Hall FC; Agard C; Anderson ME; Diot E; Madhok R; Akil M; Buch MH; Chung L; Damjanov N; Gunawardena H; Lanyon P; Ahmad Y; Chakravarty K; Jacobsen S; MacGregor AJ; McHugh N; Müller-Ladner U; Riemekasten G; Becker M; Roddy J; Carreira PE; Fauchais AL; Hachulla E; Hamilton J; Inanç M; McLaren JS; van Laar JM; Pathare S; Proudman S; Rudin A; Sahhar J; Coppere B; Serratrice C; Sheeran T; Veale DJ; Grange C; Trad GS; Herrick AL
Rheumatology (Oxford); 2018 Feb; 57(2):370-381. PubMed ID: 29207002
[TBL] [Abstract][Full Text] [Related]
10. Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database.
Allanore Y; Bozzi S; Terlinden A; Huscher D; Amand C; Soubrane C; Siegert E; Czirják L; Carreira PE; Hachulla E; Zanatta E; Li M; Airò P; Mendoza FA; Rosato E; Distler O;
Arthritis Res Ther; 2020 Oct; 22(1):257. PubMed ID: 33115544
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients.
Suliman YA; Kafaja S; Alemam M; Shaweesh Y; Tavakoli K; Furst DE
J Scleroderma Relat Disord; 2021 Oct; 6(3):236-241. PubMed ID: 35387210
[TBL] [Abstract][Full Text] [Related]
12. Do We Have Good Activity Indices in Systemic Sclerosis?
Groseanu L; Petrescu S; Balanescu A; Bojinca V; Opris-Belinski D; Berghea F; Mazilu D; Saulescu I; Borangiu A; Daia-Iliescu S; Constantinescu C; Cobilinschi C; Abobului M; Negru MM; Ionescu R
Curr Rheumatol Rev; 2022; 18(1):39-47. PubMed ID: 34517805
[TBL] [Abstract][Full Text] [Related]
13. Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
Zampatti N; Garaiman A; Jordan S; Dobrota R; Becker MO; Maurer B; Distler O; Mihai C
Arthritis Res Ther; 2021 Apr; 23(1):125. PubMed ID: 33888149
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a patient-reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale.
Sibeoni J; Dunogué B; Dupont A; Haiddar D; Benmostefa N; Falissard B; Mouthon L; Révah-Levy A; Verneuil L
Br J Dermatol; 2022 Jan; 186(1):96-105. PubMed ID: 34355380
[TBL] [Abstract][Full Text] [Related]
15. Sexual function in Italian women with systemic sclerosis is affected by disease-related and psychological concerns.
Maddali Bongi S; Del Rosso A; Mikhaylova S; Baccini M; Matucci Cerinic M
J Rheumatol; 2013 Oct; 40(10):1697-705. PubMed ID: 23996290
[TBL] [Abstract][Full Text] [Related]
16. Fatigue and its relationship with disease-related factors in patients with systemic sclerosis: A cross-sectional study.
Yakut H; Özalevli S; Birlik AM
Turk J Med Sci; 2021 Apr; 51(2):530-539. PubMed ID: 32927933
[TBL] [Abstract][Full Text] [Related]
17. Validation of disease activity indices using the 28 joint counts in systemic sclerosis.
Lóránd V; Bálint Z; Komjáti D; Németh B; Minier T; Kumánovics G; Farkas N; Czirják L; Varjú C;
Rheumatology (Oxford); 2016 Oct; 55(10):1849-58. PubMed ID: 27402873
[TBL] [Abstract][Full Text] [Related]
18. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
19. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
[TBL] [Abstract][Full Text] [Related]
20. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
